Study Design. Prospective analysis of patients fused with freeze-dried corticancellous allograft, local bone graft, and recombinant human bone morphogenetic protein (rhBMP-2) (Infuse) studied for a minimum follow-up of 24 months.
Posterolateral lumbar fusion is indicated for certain fractures, instability (acute, degenerative, and iatrogenic), and some painful degenerative disc disease states (spondylolisthesis, spondylosis, and scoliosis), and certain cases of infection and tumor. 1 Solid arthrodesis has been directly correlated with improved outcomes. 2 Instrumentation has been shown to increase fusion rates. [2] [3] [4] The often stated "gold standard" for fusion includes autogenous iliac crest bone graft (ICBG). 5 With autogenous ICBG and rigid fixation, posterolateral spinal fusion of the lumbar spine can achieve rates in excess of 90%. The morbidity of ICBG harvest includes chronic donor site pain, which has been reported to range from 15% to 39%. Proven alternatives to autogenous ICBG harvest are few, and efforts to achieve comparable posterolateral fusion rates with other bone products or components remain a reasonable goal. 6, 7 In posterolateral fusions, allograft alone acts primarily as an osteoconductive material with poor fusion rates if used alone in posterolateral lumbar fusions. 8 Allograft is often used as a graft extender if the quantity or quality of autogenous bone graft is insufficient. Allograft has been reported to give high fusion rates in pediatric scoliosis surgery. 9 Urist et al first identified a component of allograft bone thought to induce bone formation called bone morphogenetic protein (BMP). 10 -14 A 40-mg dose of recombinant human BMP-2 (rhBMP-2) with tricalcium phosphate/hydroxyapatite blended ceramic carrier has resulted in 100% fusion rates in instrumented single level cases reported by Boden et al. 5 Currently 2 BMP's are commercially available; recombinant human BMP-2 (rh-BMP-2) Infuse bone graft (Medtronic Sofamor Danek, Memphis, TN) and OP-1 (BMP-7), is available under Humanitarian Device Exemption (HDE) regulatory status, (Stryker Biotech, Hopkinton, MA). 15, 16 Given this understanding, this study was designed to investigate the combination of rhBMP-2 with allographic bone and limited local bone graft as a fusion model instead of ICBG. 
Materials and Methods
Patients were selected as a prospective consecutive case series based on their indications for surgery of neurogenic claudication and associated back pain. Patients were selected for surgery based on their extremity based pain, radiculitis/radiculopathy, or neurogenic claudication. Fusion was added for "painful" degenerative disc disease, degenerative spondylolisthesis, or degenerative scoliosis. Only cases requiring 1 or 2 level fusions were included and the decompression and laminectomy levels were only at the fusion levels. Average follow-up was 28.6 months (range, 24 -34 months). No patient was lost to follow-up. All patients consented to be included in the study and IRB physician directed study approval was obtained. No patient with osteoporosis (T score ϽϪ2.0) was included in the study.
About 36 patients were included in the study, consisting of 8 males and 28 females. The average age was 66.3 years with a range of 34 to 87 years. The average age, preoperative diagnosis, and biographical data were collected. Five patients were smokers (14%). All patients had to quit smoking to be included in this study. No anti-inflammatory medications were allowed for a minimum of 3 months after surgery. There were 20 onelevel fusions and 16 two-level fusions.
The surgical technique was similar in all patients. Graft bed preparation, decompression, and segmental rigid spinal fixation were performed as follows: the soft tissue and muscle were removed from the lateral aspect of the superior articular facets at each level of the transverse process exposure. The intertransverse process ligament was released from the transverse process and a spinous process local graft was positioned under the edge of the adjacent transverse processes. Autogenous bone from the laminectomy was admixed (about 10 mL total) and used with freezedried allograft. A large II Infuse kit (12 mg of rhBMP-2, 1.5 mg/ mL) was used, dividing the 3 ϫ 4 inch sponge in half for each side. A layered application was done as shown in Table 1 . The bone morphogenetic protein impregnated followed by allograft and another layer of BMP impregnated collagen sponge and allograft. A total of 20 mL of freeze-dried corticancellous allograft was added per level per side. Irrigation was limited after fusion materials were implanted. Facet arthrodesis was done with local autogenous bone from the lamina after decortications.
Other surgical data were recorded, including estimated blood loss, dural injury, infection, and surgical time. All patients were given a semirigid corset to wear for a minimum of 6 weeks after surgery when out of bed.
Outcomes were measured as to an 11-point range (0 -10) verbal rating scale (VRS) for back and leg pain with Oswestry Disability Index (ODI) and SF-36 Health Survey. Fusion was judged historically by the plain radiographic classification of Lenke et al.
Standing flexion and extension radiographs were taken and instability was defined as translation of more than 3 mm and angulation between adjacent segments of more than 10°. More importantly, reconstructed computed tomography (CT) scans were collected for all patients. Fusion by CT scan was defined as bone formation against the transverse processes with bridging trabeculation between the transverse processes. The radiograph and CT results were interpreted by an independent radiologist blinded as to the type of graft material used for posterolateral fusion. The Student t test was used when appropriate for preoperative to postoperative analyses. The level of significance was set at P Ͻ 0.05.
Results
The peri-and postoperative verbal rating scales revealed decreased back and leg pain. The average back pain changed from 7.7 to 3.9 and average leg pain also decreased from 6.02 to 2.02 (P Ͻ 0.05). This change is expected since the extremity pain drove the operative decision and most patients were treated for spinal stenosis with neurogenic claudication. The pre-and postoperative ODI improved from 54 to 14 (P Ͻ 0.05). The SF-36 showed improvements overall but significantly in the areas of bodily pain, vitality, mental health, and social functioning (P Ͻ 0.05). The Lenke grading system showed fusion (grades 1 and 2) versus nonunion (grades 3 and 4) to be 88.4%.
The CT scans were viewed for bridging of bone between the transverse processes as well as incorporation of bone between the transverse processes as a solid fusion. Fusion was judged to be present in 97.2% of the patients by sagittal and coronal CT scan analysis. Bone quality, incorporation, and the radiograph and CT appearance is shown in Figures 1 to 3 average follow-up, no patient has been revised for nonunion or instrumentation failure although 1 patient appeared to have a nonunion by plain film, flexion and extension views, and CT scanning. Complications were typical for this type of surgery. There was 1 dural tear, but no infections.
Discussion
The goal of fusion surgery in the lumbar spine is solid arthrodesis, which correlates with a positive outcome. Donor site pain was not noted in this study, which was obviated by the use of rhBMP-2, local bone graft, and allograft. Although not quantified, it appeared that the patients had less postoperative pain and a relatively quicker initial recovery. The fusion quality was somewhat less dense than might be ideal, but clinical outcomes and revision rates suggest that it is adequate. Boden et al used more than a triple dose of rhBMP-2 (40 mg) on a ceramic carrier compared to the commercially available 12 mg doses of rhBMP-2 on an absorbable collagen sponge (ACS) used in this study. 5 He demonstrates fusion with iliac crest bone graft and Infuse. 5 The ideal dose response curve is not known but from these data a higher dose seems beneficial but not necessary for 1 or 2 level fusions as shown in this preliminary study. The facet joints were decorticated and grafted with local bone graft in all cases which may have helped with stabilization and fusion of the instrumented motion segment. The geometry of the rhBMP-2/ACS and allograft was applied as a sandwich shaped or layered model in this study. Other studies used a rolled or taco shape. 5, 12 The contact area and geometry of the collagen sponge impregnated with rhBMP-2 seems to guide the shape, volume, and thickness of the final fusion mass. The collagen sponge with the bound rhBMP-2 was positioned on the decorticated transverse process and the autogenous spinous process strut graft with allograft then packed onto the collagen sponge impregnated with the rhBMP-2 and layered in this model. The process was then repeated with an additional piece of collagen sponge impregnated with morphogenetic protein followed by additional allograft bone. This overall technique would be similar to that of an augmentation of a fusion where autogenous bone was placed and allograft bone was then used on top to augment the osteoconductive fusion mass. The use of an autogenous spinous process graft could be criticized as not being a pure rhBMP-2/ACS and allograft model. However, in clinical practice, this is realistic since the use of spinous process and laminar bone is readily available and does not require harvest of the iliac crest. Use of local bone further obviated the need to harvest bone graft material from the iliac crest in which pain and morbidity are associated.
The use of freeze-dried allograft as a graft expander or osteoconductive material is well established. 8 Since Urist et al isolated bone morphogenetic protein from allograft, this makes a logical choice as an osteoconductive material to use with rhBMP-2.
14 Allograft is readily accessible and relatively inexpensive and disease free if it is freezedried. Fresh frozen allograft may offer biologic advantage but was not chosen in our study for concern of disease transmission. CT scan was used since this has become the standard to judge arthrodesis and posterolateral fusions of the lumbosacral spine. 5 Postoperative CT scanning is superior to plain films in assessing bone formation and attachment to the transverse processes since it can exclude the instrumentation to a large extent. In clinical practice, routine CT may not be necessary if plain radiographs (dynamic radiographs as well) and clinical outcomes are supportive of fusion. Figure 4 showing the formation of bone with allograft and rhBMP-2/ACS. Bridging bone is noted between and on the transverse processes and sacral alae.
Concerns for protein sensitivity from the bone morphogenetic protein and other related complications were fortunately not seen in this small series. At this point, the morbidity associated with the harvest of posterior iliac crest bone graft seems to be outweighed in comparison to the advantages of rhBMP-2. 17 Historically, donor site pain is the most commonly reported complication. Other authors argue that this is not so but some of the most dissatisfied patients in our practice have chronic iliac crest donor site pain. Fusion rates are at least as good as autogenous iliac crest bone graft but should be interpreted in light of the relative small series and intermediate follow-up ranges shown in our review.
Complications noted were minimal. Where possible, reduction of the deformity was achieved by prone positioning but was felt to be a driving factor in the surgical procedure (22 of 28 patients). Use of the instrumentation was such as to not force a correction in a particular patient with spondylolisthesis or a scoliotic segment intraoperatively.
Patients improved statistically and clinically significantly from preop to postop. Average back pain was decreased by 3.8 points (7.7-3.9, an average of 49%), leg pain was decreased by 4 points (6.02-2.02, an average of 66%), ODI improved by 40 points (54 -14) and SF-36 health survey physical component score (PCS) improved by 8 points. The patients were primarily chosen for surgery due to their leg or extremity complaints and inability to stand and walk. These subjective lower extremity complaints were markedly relieved, 83.9% on average. The ODI was also improved by 47%. It appears that laminectomy with instrumented fusion in the properly selected patient will decrease but not eliminate back pain completely. Values used for MCID were the same as Glassman et al. 18 A change of 10.0 points for the ODI, 5.42 points for the SF-36 PCS, 1.6 points for back pain VRS, and 1.1 points for leg pain VRS. This implicates that this surgery met the MCID values set by Glassman et al and it significantly improved the patient's quality of life.
Conclusion
In summary, 36 patients were treated for spinal stenosis and secondary degenerative disc disease with direct decompression and instrumented 1 and 2 level posterolateral fusion. Instead of iliac crest autogenous bone graft, rhBMP-2/ACS, freeze-dried corticancellous allograft, and local autogenous bone graft were used. Analysis clinically and by CT and radiograph revealed CT proved fusion rates of 97.2% and plain radiographs fusion rates were 88.4%. Statistically significant improvements in SF-36, ODI and Verbal Rating Scale of back and leg pain from preoperative to postoperative were noted. Allograft, local bone graft, and Infuse (12 mg/1.5 mg/mL) provided high rates of fusion in 1 and 2 level fusions with instrumentation. Complications were minimal and consistent with this type of lumbar surgery. MCID's were exceeded in all outcome categories.
Key Points
• Instrumented 1 and 2 level posterolateral fusions can consistently occur with rhBMP-2, allograft, and local bone graft. Although, the optimal rh-BMP-2 dose per level is not established.
• This technique may offer a potential substitute for iliac crest bone graft.
• Results, outcomes, and complications were minimal and consistent with this type of surgery. 
